Drug Development and FDA Review Process

Поделиться
HTML-код
  • Опубликовано: 11 май 2022
  • Judy Heidebrink, M.D., M.S., Richard and Katherine M. O’Connor Research Professor Alzheimer’s Disease

Комментарии • 1

  • @HawkinsReece
    @HawkinsReece 2 дня назад

    It's amazing, the blogger is really creative and worth watching